Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
Dig Dis Sci. 2011 Oct;56(10):2928-38. doi: 10.1007/s10620-011-1751-6. Epub 2011 May 31.
The prevalence of generalized transit delay and relation to symptoms in suspected gastroparesis, intestinal dysmotility, or slow transit constipation are unknown.
The aims of this study were (1) to define prevalence of generalized dysmotility using wireless motility capsules (WMC), (2) to relate to symptoms in suspected regional delay, (3) to compare results of WMC testing to conventional transit studies to quantify new diagnoses, and (4) to assess the impact of results of WMC testing on clinical decisions.
WMC transits were analyzed in 83 patients with suspected gastroparesis, intestinal dysmotility, or slow transit constipation.
Isolated regional delays were observed in 32% (9% stomach, 5% small bowel, 18% colon). Transits were normal in 32% and showed generalized delays in 35%. Symptom profiles were similar with normal transit, isolated delayed gastric, small intestinal, and colonic transit, and generalized delay (P = NS). Compared to conventional tests, WMC showed discordance in 38% and provided new diagnoses in 53%. WMC testing influenced management in 67% (new medications 60%; modified nutritional regimens 14%; surgical referrals 6%) and eliminated needs for testing not already done including gastric scintigraphy (17%), small bowel barium transit (54%), and radioopaque colon marker tests (68%).
WMC testing defines localized and generalized transit delays with suspected gastroparesis, intestinal dysmotility, or slow transit constipation. Symptoms do not predict the results of WMC testing. WMC findings provide new diagnoses in >50%, may be discordant with conventional tests, and can influence management by changing treatments and eliminating needs for other tests. These findings suggest potential benefits of this method in suspected dysmotility syndromes and mandate prospective investigation to further define its clinical role.
目前尚不清楚广泛性转运延迟的流行程度及其与疑似胃轻瘫、肠道动力障碍或慢传输性便秘的症状之间的关系。
本研究的目的是(1)使用无线动力胶囊(WMC)定义广泛性动力障碍的流行程度,(2)将其与疑似区域性延迟的症状相关联,(3)将 WMC 检测结果与传统传输研究进行比较,以量化新诊断,并(4)评估 WMC 检测结果对临床决策的影响。
分析了 83 例疑似胃轻瘫、肠道动力障碍或慢传输性便秘患者的 WMC 转运情况。
观察到孤立性区域性延迟占 32%(9%为胃,5%为小肠,18%为结肠)。32%的转运正常,35%的转运显示广泛延迟。症状谱与正常转运、孤立性胃延迟、小肠和结肠延迟以及广泛延迟相似(P=NS)。与传统检测相比,WMC 在 38%的情况下存在不一致,并提供了 53%的新诊断。WMC 检测影响了 67%的治疗(新药物治疗 60%;修改营养方案 14%;手术转诊 6%),并消除了对未进行的检测的需求,包括胃闪烁扫描(17%)、小肠钡剂转运(54%)和放射性结肠标志物检测(68%)。
WMC 检测可确定疑似胃轻瘫、肠道动力障碍或慢传输性便秘患者的局部和广泛转运延迟。症状不能预测 WMC 检测的结果。WMC 发现可提供>50%的新诊断,可能与传统检测不一致,并通过改变治疗方法和消除对其他检测的需求来影响治疗。这些发现表明,该方法在疑似动力障碍综合征中有潜在的益处,需要进行前瞻性研究以进一步确定其临床作用。